Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Biomarkers, Tumor
  • GPI-Linked Proteins
  • Lung Neoplasms
  • Neoplasm Recurrence, Local

abstract

  • MSLN expression in patients with early-stage lung ADC is associated with increased risk of recurrence and reduced OS, indicating that MSLN expression is a molecular marker of tumor aggressiveness and a potential target for therapy.

publication date

  • February 26, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3944669

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-13-1862

PubMed ID

  • 24334761

Additional Document Info

start page

  • 1020

end page

  • 8

volume

  • 20

number

  • 4